Attainment of at least a very good partial response after induction treatment is an important surrogate of longer survival for multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Attainment of at least a very good partial response after induction treatment is an important surrogate of longer survival for multiple myeloma

Published:2010-02-15 Issue:11 Volume:45 Page:1625-1630
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Tan D,Lao Z,Loh Y,Ng H J,Chuah C,Wong G C,Koh M,Linn Y C,Lim L C,Tien S L,Lee L H,Goh Y T,Hwang W

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt201025.pdf

Reference38 articles.

1. Attal M, Harousseau JL, Facon T, Guilhot F, Doyen C, Fuzibet JG et al. Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med 2003; 349: 2495–2502.

2. Barlogie B, Tricot G, Anaissie E, Shaughnessy J, Rasmussen E, van Rhee F et al. Thalidomide and hematopoietic-cell transplantation for multiple myeloma. N Engl J Med 2006; 354: 1021–1030.

3. Cavo M, Di Raimondo F, Zamagni E, Patriarca F, Tacchetti P, Casulli AF et al. Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myeloma. J Clin Oncol 2009; 27: 5001–5007.

4. Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 2003; 348: 1875–1883.

5. Lahuerta JJ, Martinez-Lopez J, Serna JD, Bladé J, Grande C, Alegre A et al. Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patients. Br J Haematol 2000; 109: 438–446.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Autologous Stem Cell Transplantation for Myeloma Patients with Suboptimal Response: A Multicenter Retrospective Analysis;Transplantation and Cellular Therapy;2023-11

2. Use of depth of response to predict progression-free survival in relapsed or refractory multiple myeloma: Evaluation of results from 102 clinical trials;Hematological Oncology;2018-04-19

3. Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma;Cancer;2017-05-17

4. Association between response rates and survival outcomes in patients with newly diagnosed multiple myeloma. A systematic review and meta-regression analysis;European Journal of Haematology;2017-03-20

5. The Singapore Myeloma Study Group Consensus Guidelines for the management of patients with multiple myeloma;Singapore Medical Journal;2017-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3